Newsletters

06.23.20

Benefits of Capping Medicare Part D Out-of-Pocket Costs Vary Substantially Across Drugs

Although delayed as a result of the COVID-19 public health emergency, there are persistent and ongoing efforts to reform the Medicare Part D benefit.


06.22.20

Drug Manufacturers Asked to Correct Medicaid Drug Data

Drug manufacturers should immediately evaluate whether they have been correctly classifying their products in data submitted to the Medicaid Drug Rebate Program (MDRP) to minimize penalties they could face for any errors.


06.19.20

FCC Approves 11th Set of COVID-19 Telehealth Program Applications

The Federal Communications Commission (FCC) has approved its 11th set of COVID-19 telehealth program applications, totaling $23.25 million for 62 providers.


06.19.20

NYS Department of Health Issues Guidance on Application Process for Midwifery Birth Centers

The New York State Department of Health (DOH) recently issued guidance on the new Certificate of Need (CON) licensure process for freestanding midwifery birth centers (also, MBCs).


06.18.20

Strategies for Supporting and Strengthening Medicaid IT During the COVID-19 Crisis

Long-standing federal statute and regulations authorize federal matching funds for automated data processing (ADP) systems for the state administration of Medicaid, the Children’s Health Insurance Program (CHIP) and human services programs, and establish the rules and process for states to ...


06.17.20

The Digital Health Investment Landscape Post-COVID-19

During the COVID-19 crisis, there remains a lot of activity and interest in digital health.


06.16.20

Navigating FDA’s Wave of Enforcement Discretion Policies: Device Availability in the Era of COVID-19

Using the Emergency Use Authorization (EUA) process, the Food and Drug Administration (FDA) has taken enormous steps in the last two months to promote vaccine and therapy development and availability, as well as facilitate availability of diagnostic tests, ventilators, personal protective equipment ...


06.16.20

Manatt Provides Recommendations to State of New Jersey Following Rapid Review of Nursing Homes

Based on an intensive three-week review commissioned by New Jersey, the report outlines a set of actionable proposals for the state to reduce the impact of future COVID-19 outbreaks in nursing homes and strengthen the state’s long-term care (LTC) system.


06.15.20

Emergence From COVID-19: Imperatives for Health System Leaders

In a new briefing, Manatt examines the challenges health system leaders are facing throughout COVID-19, imperatives for moving forward & actionable recommendations.


06.11.20

HRSA Issues Guidance Expediting 340B Eligibility for Patients of New Hospital Outpatient Clinics

In a frequently asked question (FAQ) published late last week, the Health Resources and Services Administration (HRSA) indicated that patients of certain offsite outpatient clinics of hospitals that participate in the prescription drug pricing program established under Section 340B of the federal ...